ONTEX Ontex Group N.V.

Ontex reaches important milestone in reshaping its portfolio with binding agreement to sell its Brazilian business to Softys

Ontex reaches important milestone in reshaping its portfolio with binding agreement to sell its Brazilian business to Softys

Aalst, Belgium, September 30, 2024 – Ontex Group NV (Euronext: Ontex), a leading international developer and producer of personal care products, announces that it has entered into a binding agreement to sell its Brazilian business activities to Softys S.A. for an enterprise value of BRL 671 million (or approximately €110 million*). Softys is a personal hygiene company with operations across Latin America, that also acquired Ontex’s Mexican business activities in 2023. It is a wholly owned subsidiary of Empresas CMPC S.A., which is headquartered in Chile.

Gustavo Calvo Paz, Ontex’s CEO, said: “This divestment represents another major milestone towards Ontex’s ambitioned portfolio, focusing on retail brands and healthcare in Europe and North America. Moreover, the proceeds from the sale will further reduce our indebtedness, putting us in an even stronger position to execute our transformation. I am convinced that Softys, with its 40 years of experience in the personal hygiene market in Latin America, is well placed to take the business forward, benefiting from the talent and expertise of our teams, as they also did with our Mexican business.”

The transaction includes Ontex’s business in Brazil and its manufacturing facility in Senador Canedo in the State of Goiás. The business develops, manufactures, commercializes and distributes diapers and pants for the baby care market under the PomPom, Cremer, Sapeka and Turma da Mônica brands, as well as for the adult care market under the Bigfral brand. It has approximately 1,400 employees and contributed revenue of €97 million and adjusted EBITDA of €13 million to the Group in the first half of 2024.

Subject to customary balance sheet adjustments, the net proceeds of the transaction, after deduction of tax-related payments and transaction fees, are expected to be approximately €82 million*, of which up to €18 million* will be held in escrow. The transaction will generate a net gain on disposal of approximately €39 million* and trigger the recognition of a non-cash accounting loss of approximately €(140) million* related to the accumulated currency translation reserves.

Ontex and Softys aim to close the transaction, which is subject to customary conditions, including merger clearance from the Brazilian antitrust authority, during the first half of 2025.

[*] All amounts in € are based on the current BRL/EUR exchange rate, and can therefore change by the time of finalization of the transaction.

Enquiries

  • Investors        Geoffroy Raskin                 
  • Media              Maarten Verbanck               

About Ontex

Ontex is a leading international developer and producer of care products and solutions for retailers and healthcare, with expertise in baby care, feminine care and adult care. Ontex’s innovative products are distributed in around 100 countries through retailers and healthcare providers. Employing some 7,500 people, Ontex has a presence in 14 countries, with its headquarters in Aalst, Belgium. Ontex is listed on Euronext Brussels and is part of the Bel Mid®. To keep up with the latest news, visit or follow Ontex on , , and .

Attachment



EN
30/09/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ontex Group N.V.

Carole Braudeau
  • Carole Braudeau
CS AXA
CEC CECONOMY AG ... (+13)

Credit Morning 08/01/2025

S&P lowers outlook to negative vs. stable on ELO's 'BB-' rating|ZF H1 25 results: Better than one could have feared… but some water into the wine|Emeria announces the sale of Assurimo|Viridien: Profitability improvement, good FCF generation, and guidance confirmed|

Carole Braudeau
  • Carole Braudeau
CS AXA
CEC CECONOMY AG ... (+13)

Morning Crédit 01/08/2025

ELO : S&P abaisse la perspective de stable à négative sur le rating BB-|ZF H1 25 results: Better than one could have feared… but some water into the wine|Emeria annonce la cession d’Assurimo|Viridien: Profitability improvement, good FCF generation, and guidance confirmed|

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

AB InBev: 2Q25 results. Air France-KLM: Nice beat, let's see how FY25 finishes. AMG: Uptrend continues in 2Q25 with 23% EBITDA beat and guidance up to +US$200m. Aperam: Slight 2Q25 EBITDA beat, 3Q25 seen down QoQ. Arcadis: EBITA margin held up well in 2Q25, order intake mixed. Ayvens: 2Q25 results. Azelis: Soft but largely in-line 2Q25 with EMEA offsetting weaker APAC. Bekaert: 1H25 miss and lowered outlook to result in c.5% consensus downside. Corbion: Taking it to the wire. dsm...

Hilde Van Boxstael ... (+7)
  • Hilde Van Boxstael
  • Jacob Mekhael
  • Michiel Declercq
  • Thibault Leneeuw
  • Thomas Couvreur
  • Wim Hoste
  • Wim Lewi

Morning Notes : ABI BB, ARGX BB, BEKB BB, CRBN NA, DSFIR NA, ENX FP, F...

: ABI BB, ARGX BB, BEKB BB, CRBN NA, DSFIR NA, ENX FP, FAGR BB, FLOW NA, INGA NA, ONTEX BB, UCB BB, AZE BB, SYENS BB

 PRESS RELEASE

Ontex confirms H1 results with revenue and margin decrease in a weaker...

Ontex confirms H1 results with revenue and margin decrease in a weaker-than-expected market, while investing significantly and reaching key transformation milestones Regulated information Revenue drop by 4% in H1, caused mainly by weak baby care demand in Europe;Adj. EBITDA margin down by 2.2pp in H1, due to lower fixed cost absorption caused by lower volumes, and a rising cost environment;Expecting low single digit revenue contraction for full year 2025 and adj. EBITDA in €200-210 million range. CEO quote Gustavo Calvo Paz, Ontex’s CEO, said: “The weak first half of the year, while disa...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch